{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:07:35Z","timestamp":1794611255432,"version":"4.9.1"},"reference-count":117,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>Oral contraceptive pills (OCPs) have been used as effective and popular forms of contraception since the middle of the last century. By 2019, over 150 million reproductive-aged individuals were using OCPs to prevent unintended pregnancies worldwide. Safety concerns regarding the effects of OCPs on blood pressure were reported soon after these pills gained approval. Although OCP doses were subsequently reduced, epidemiologic evidence continued to support a smaller, but significant association between OCPs and hypertension. Given the rising prevalence of hypertension, as well as the adverse effects of cumulative exposure to blood pressure elevations on cardiovascular disease risk, understanding the nature of the association between OCPs and hypertension is important for clinicians and patients to assess the risks and benefits of use, and make individualized decisions regarding contraception. Therefore, this review summarizes the current and historical evidence describing the association between OCP use and blood pressure elevations. Specifically, it identifies the pathophysiologic mechanisms linking OCPs to hypertension risk, describes the magnitude of the association between OCPs and blood pressure elevations, and distinguishes the effects of various OCP types on blood pressure. Finally, it describes current recommendations regarding hypertension and OCP use, as well as identifies strategies, such as over-the-counter OCP prescribing, to safely and equitably improve access to oral contraception.<\/jats:p>","DOI":"10.1161\/hypertensionaha.122.20018","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T05:00:32Z","timestamp":1676523632000},"page":"924-935","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":89,"title":["Oral Contraceptive Pills and Hypertension: A Review of Current Evidence and Recommendations"],"prefix":"10.1161","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0613-7580","authenticated-orcid":true,"given":"Natalie A.","family":"Cameron","sequence":"first","affiliation":[{"name":"Northwestern University Feinberg School of Medicine, Department of Medicine, Division of General Internal Medicine, Chicago, IL (N.A.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciantel A.","family":"Blyler","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (C.A.B., N.A.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3257-3623","authenticated-orcid":true,"given":"Natalie A.","family":"Bello","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (C.A.B., N.A.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","volume-title":"Contraceptive Use by Method 2019: Data Booklet","year":"2020","unstructured":"United Nations: Department of Economic and Social Affairs. Contraceptive Use by Method 2019: Data Booklet. United Nations; 2020."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.4158"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)02358-1"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.94.3.483"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6667.165"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/jech.48.3.324"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0195-668x(02)00752-2"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2018.03.005"},{"key":"e_1_3_3_10_2","unstructured":"US Medical Eligibility Criteria (US MEC) for Contraceptive Use 2016. 2022. https:\/\/www.cdc.gov\/reproductivehealth\/contraception\/mmwr\/mec\/summary.html. Accessed October 17 2022."},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11660"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.5888\/pcd16.190105"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15650"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/13625187.2010.513071"},{"key":"e_1_3_3_15_2","unstructured":"Eisenstadt v. Baird 405 U.S. 438 (1972). Justia Law. https:\/\/supreme.justia.com\/cases\/federal\/us\/405\/438\/. Accessed September 28 2022."},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2012.11.004"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(71)90008-7"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S22645"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10235625"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2021.05.002"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2009.11.001"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/13697130902905757"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw016"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/9781119211457"},{"key":"e_1_3_3_25_2","unstructured":"Progestin-Only Pills. 2019. https:\/\/www.cdc.gov\/reproductivehealth\/contraception\/mmwr\/spr\/progestin.html. Accessed October 18 2022."},{"key":"e_1_3_3_26_2","volume-title":"In: StatPearls","author":"Cooper DB","year":"2022","unstructured":"Cooper, DB, Patel, P, Mahdy, H. Oral Contraceptive Pills. In: StatPearls. StatPearls Publishing; 2022."},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(69)90169-x"},{"key":"e_1_3_3_28_2","first-page":"167","article-title":"Hypertension associated with oral contraceptives.","volume":"95","author":"Hutchings HR","year":"1966","unstructured":"Hutchings, HR. Hypertension associated with oral contraceptives. Can Med Assoc J. 1966;95:167.","journal-title":"Can Med Assoc J"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-71-5-891"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.11.3_pt_2.ii11"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.34.12.1238"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1970.00310100067006"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5907.533"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199715100-00003"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2007.01.007"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6874-13-39"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2010.67"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2011.157"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1353\/hpu.2013.0172"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.285.6339.403"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018155"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.03.383"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-021-01147-4"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13042"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/2047487318774847"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(80)90860-1"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(72)90811-3"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1984.tb04747.x"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(95)00153-2"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(93)90034-5"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.07.063"},{"key":"e_1_3_3_52_2","unstructured":"Risk of Venous Thromboembolism Among Users of Drospirenone-Containing Oral Contraceptive Pills. 2012. https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2012\/11\/risk-of-venous-thromboembolism-among-users-of-drospirenone-containing-oral-contraceptive-pills. Accessed November 25 2022."},{"key":"e_1_3_3_53_2","unstructured":"Update - Dienogest and risk of venous thromboembolism. Therapeutic Goods Administration (TGA). 2022. https:\/\/www.tga.gov.au\/news\/safety-updates\/update-dienogest-and-risk-venous-thromboembolism. Accessed November 25 2022."},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-008-0907-x"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.02.009"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.6.7775629"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.conx.2020.100020"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2015.07.014"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2022.10.004"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2014.05.011"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1152\/advan.00049.2009"},{"key":"e_1_3_3_62_2","volume-title":"In: StatPearls","author":"Fountain JH","year":"2022","unstructured":"Fountain, JH, Lappin, SL. Physiology, Renin Angiotensin System. In: StatPearls. StatPearls Publishing; 2022."},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(76)90480-4"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.5.3.353"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199204000-00007"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-33-4-671"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.38.1.35"},{"key":"e_1_3_3_68_2","first-page":"643","article-title":"Effect of oral contraceptive therapy on the renin-angiotensin system in normotensive and hypertensive women.","volume":"41","author":"Tapia HR","year":"1973","unstructured":"Tapia, HR, Johnson, CE, Strong, CG. Effect of oral contraceptive therapy on the renin-angiotensin system in normotensive and hypertensive women. Obstet Gynecol. 1973;41:643\u2013649.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-34-6-1067"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016348209155314"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.2001.280.3.R807"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.33.1.90"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.36660\/ijcs.20180021"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.05179"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.102.13.1473"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13547"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-4-431-56012-8_3"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200104000-00008"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1517\/14622416.3.1.57"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2010.10.011"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2022.2054413"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2021.01.001"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)12393-8"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00079.x"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.09.042"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.038659"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0010-7824(03)00073-8"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2005.08.005"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0010-7824(97)00204-7"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.1.72"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(98)00041-9"},{"key":"e_1_3_3_92_2","volume-title":"Medical Eligibility Criteria for Contraceptive Use","year":"2015","unstructured":"Medical Eligibility Criteria for Contraceptive Use. World Health Organization; 2015. https:\/\/www.who.int\/publications\/i\/item\/9789241549158. Accessed October 17, 2022."},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003072"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1701-2163(16)30043-3"},{"key":"e_1_3_3_95_2","unstructured":"FSRH Clinical Guideline: Combined Hormonal Contraception (January 2019 Amended November 2020). https:\/\/www.fsrh.org\/standards-and-guidance\/documents\/combined-hormonal-contraception\/. Accessed October 17 2022."},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2016.10.005"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000065"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwab121"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.18986"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003020"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0000000000001043"},{"key":"e_1_3_3_102_2","unstructured":"Centers for Disease Control and Prevention. Combined Hormonal Contraceptives. 2019. https:\/\/www.cdc.gov\/reproductivehealth\/contraception\/mmwr\/spr\/combined.html. Accessed January 31 2023."},{"key":"e_1_3_3_103_2","unstructured":"Over-the-Counter Access to Hormonal Contraception; 2012. https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2019\/10\/over-the-counter-access-to-hormonal-contraception. Accessed October 27 2022."},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1055\/a-1259-1609"},{"key":"e_1_3_3_105_2","unstructured":"ACOG Statement on FDA Submission for Over-the-Counter Access to Contraception; 2022. https:\/\/www.acog.org\/news\/news-releases\/2022\/07\/acog-statement-on-fda-submission-for-over-the-counter-access-to-contraception. Accessed October 24 2022."},{"key":"e_1_3_3_106_2","unstructured":"Over-the-Counter Oral Contraceptives. 2019. https:\/\/www.aafp.org\/about\/policies\/all\/otc-oral-contraceptives.html. Accessed October 23 2022."},{"key":"e_1_3_3_107_2","unstructured":"AMA urges FDA to make oral contraceptive available over-the-counter. American Medical Association; 2022. https:\/\/www.ama-assn.org\/press-center\/press-releases\/ama-urges-fda-make-oral-contraceptive-available-over-counter. Accessed October 29 2022."},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2012.11.021"},{"key":"e_1_3_3_109_2","unstructured":"Pharmacist-Prescribed Contraceptives. Guttmacher Institute. 2020. https:\/\/www.guttmacher.org\/state-policy\/explore\/pharmacist-prescribed-contraceptives. Accessed October 29 2022."},{"key":"e_1_3_3_110_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31818345f0"},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31820b0244"},{"key":"e_1_3_3_112_2","doi-asserted-by":"publisher","DOI":"10.1177\/1357633X18824828"},{"key":"e_1_3_3_113_2","doi-asserted-by":"publisher","DOI":"10.1363\/4217610"},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1506575"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40834-020-00118-5"},{"key":"e_1_3_3_116_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2017.04.003"},{"key":"e_1_3_3_117_2","doi-asserted-by":"publisher","DOI":"10.1111\/jftr.12472"},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2020.8905"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.122.20018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T12:40:28Z","timestamp":1750855228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.122.20018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":117,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.122.20018"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.122.20018","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"2023-02-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}